Dr. Jean Roy is a member of the Hematopoietic Stem Cell Transplant Clinical Research Unit. He is particularly interested in multiple myeloma and allogeneic transplantation to cure this disease. His projects aim to make allogeneic transplantation more effective and less toxic for patients, for example, through the use of myeloma drugs post-transplantation or the use of cord cells expanded with UM171 to achieve a more potent antimyeloma effect.